The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
about
Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profileBcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptorRe-emergence of interferon-α in the treatment of chronic myeloid leukemiaChronic myeloid leukemia stem cells and developing therapies.Biological therapy and the immune system in patients with chronic myeloid leukemia.Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms.Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.The interferon-alpha revival in CML.Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML Cells.Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America.
P2860
Q28476476-3682B711-9570-453D-BFAE-D4D53580E905Q35483727-60816AB0-869A-4D90-B14B-F474223CAD3DQ36989407-91435B2D-1A9D-4E7F-AE5E-7ED1C7254A83Q37836936-0DE80E5A-C570-4C00-AD33-3006BBC3E16EQ38015742-CB5B4639-57C3-4F5F-8FA0-E7E6F18713DAQ38046648-377C2627-6590-4C74-B667-DA875670BC95Q38095956-323E98D1-05A7-4830-AD9D-4ED5D7D9432EQ38392694-46EE1DBD-28D8-4423-B598-03006893CA7BQ40484034-53A56C2A-7BBA-4EE1-ADEB-F9011A091E16Q47806060-4FD46D36-0B5A-4DBA-95E4-AB74310630AEQ54540179-85B1E6E0-52DA-4805-92BA-9BF43DC6B4E2
P2860
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The response to imatinib and i ...... atients in early chronic phase
@ast
The response to imatinib and i ...... atients in early chronic phase
@en
The response to imatinib and i ...... atients in early chronic phase
@nl
type
label
The response to imatinib and i ...... atients in early chronic phase
@ast
The response to imatinib and i ...... atients in early chronic phase
@en
The response to imatinib and i ...... atients in early chronic phase
@nl
prefLabel
The response to imatinib and i ...... atients in early chronic phase
@ast
The response to imatinib and i ...... atients in early chronic phase
@en
The response to imatinib and i ...... atients in early chronic phase
@nl
P2093
P2860
P50
P1433
P1476
The response to imatinib and i ...... atients in early chronic phase
@en
P2093
Angela Poerio
Franca Radaelli
Giovanna Rege-Cambrin
Ivana Pierri
Monica Bocchia
Monica Crugnola
P2860
P304
P356
10.3324/HAEMATOL.2009.021246
P50
P577
2010-03-19T00:00:00Z